Bio
Dr. Ravi Majeti is an Associate Professor in the Department of Medicine, Chief of the Division of Hematology, and Member of the Institute for Stem Cell Biology and Regenerative Medicine at Stanford University. He was an undergraduate at Harvard, earned his MD and PhD from UCSF, and trained in Internal Medicine at Brigham and Women’s Hospital in Boston. Dr. Majeti completed his Hematology Fellowship at Stanford, and is a board-certified hematologist. While at Stanford, he completed post-doctoral training in the laboratory of Irving Weissman, where he investigated acute myeloid leukemia (AML) stem cells and therapeutic targeting with anti-CD47 antibodies. With Dr. Weissman, he developed a humanized anti-CD47 antibody, initiated first-in-human clinical trials, and in 2015, co-founded Forty Seven Inc. Dr. Majeti established his independent laboratory in 2009 with research focused on the molecular/genomic characterization and therapeutic targeting of leukemia stem cells in human hematologic malignancies, particularly AML. Dr. Majeti is a recipient of the Burroughs Wellcome Fund Career Award for Medical Scientists, the New York Stem Cell Foundation Robertson Investigator Award, and the Leukemia and Lymphoma Society Scholar Award.
Clinical Focus
- Hematology
Academic Appointments
-
Professor, Medicine - Hematology
-
Member, Bio-X
-
Member, Stanford Cancer Institute
Administrative Appointments
-
Chief, Division of Hematology (2017 - Present)
-
Assistant Director, Stanford Ludwig Center for Cancer Stem Cell Research (2014 - Present)
-
Co-Director, Lymphoma and Leukemia Program - Stanford Cancer Institute (2014 - Present)
-
Co-Director, Translational Research Program - Internal Medicine Residency (2013 - 2017)
Honors & Awards
-
Scholar Award, Leukemia and Lymphoma Society (2015)
-
Robertson Investigator Award, New York Stem Cell Foundation (2011)
-
Career Award for Medical Scientists, Burroughs Wellcome Fund (2008)
Boards, Advisory Committees, Professional Organizations
-
Member, American Society of Hematology - Committee on Myeloid Neoplasia (2013 - Present)
Professional Education
-
Medical Education:University of California at San Francisco School of Medicine (2002) CA
-
Residency:Brigham and Women's Hospital Harvard Medical School (2004) MA
-
Board Certification: Hematology, American Board of Internal Medicine (2007)
-
Fellowship:Stanford University Medical Center (2008) CA